The funding will support the growth of sales, marketing, and customer success operations.
"Threat intelligence is increasingly important in cyber defence and this initiative amplifies CYJAX’s mission to safeguard organisations globally from evolving cyber risks. Our unique threat intelligence platform, Cymon®, works continuously to discover and track known and unknown cyber threats targeting our customers, equiping them with higher visibility while achieving their security objectives. This new funding will help to drive business growth in a digital landscape where proactive cybersecurity measures are imperative."
Ten Eleven Ventures led the Series A round to support product development and North American expansion.
"We are delighted to welcome Ten Eleven Ventures as a new investor. This investment is a significant step in Device Authority’s journey as we continue to help new and existing customers solve their device security challenges. The wealth of knowledge and experience that our new investor and board members bring will add significant value in helping the company grow and become the market leader for delivering zero trust for IoT."
The Bristol based investigation software provider raised the capital from Frog Capital, angels and employees to fund product development and expansion.
"This funding is the latest step in our journey of supporting investigations and intelligence teams across the globe. Our mission to protect society from harm goes beyond developing intelligence and investigation software. We are building a networked community of investigation professionals across sectors worldwide to explore common challenges and share best practices."
The oversubscribed round was led by No Such Ventures to accelerate growth across the UK and Europe.
"Nearly 50% of healthcare solutions fail to make it to market due to the complex regulatory and compliance challenges they face. Those who choose to take on this complexity face overwhelming amounts of manual work and huge sums spent on consultants. That’s why we built Naq: to empower innovators in the UK and Europe to bring their solutions to market by simplifying their compliance with the frameworks required to operate in the healthcare sector."
The fintech company has raised £2m from existing backers Thomson Reuters Ventures and Love Ventures to accelerate product development and commercial growth.
"We’re reinvesting in Detected because we have a strong belief in the company’s long-term potential. As customers, we have seen first-hand the impact the technology has, and we’re excited about the momentum that Detected has developed in the market."
